All authors interested in publishing their research work in Journal of Research in Medical & Interpathy Sciences (JREMEDIS) will need to submit their manuscripts for publication through a web-based manuscript tracking system. The authors can submit new manuscript, revise their existing manuscripts, upload other required documents. They can as well track the status of their manuscripts, which are already submitted. This system helps the editorial office to communicate with the associate editors, reviewers and thus manage the peer review process. The same system is used for communication with authors. Please go to our website and register yourself (if first time user) to submit the manuscripts.

Manuscripts are received with the understanding that they contain original data that are not previously published or are being considered for publication elsewhere. Authors are required to submit the manuscript along with all concerned certificates and document. In case of any queries or additional information, you can write an e-mail to the Editor-in-Chief of the journal.

Manuscript Fees

Authors should note that there are no processing charges for publication of an article in the journal.

Plagiarism

The journal checks for plagiarism before publication. Plagiarism, including duplicate publication of the author's own work, in whole or in part without proper citation is not accepted by the journal. Manuscripts submitted to the journal will be checked for originality using anti-plagiarism software. Usually, plagiarism of ~10% (as reported by Similarity check/iThenticate) can be accepted by the journal depending on the manuscript type. However, the final decision is taken by the editors on case-to-case basis.

Copyright

The authors hold the copyright of all the editorial content published in this journal from now. All material can be used in part and full for non-commercial output after providing appropriate attribution to the original content of the journal and a link to the licence (CC-BY-NC-SA 4.0).

Licensing

All open access articles published in JPS are distributed under the terms of the CC-BY-NC-SA 4.0 license (Creative Commons Attribution-Non-Commercial Share-Alike 4.0 International License) which permits unrestricted use, distribution, and reproduction in any medium, for non-commercial purposes, provided the original work is properly cited under same licensing terms. Under Creative Commons, authors retain copyright in their articles.

Types of Submissions Accepted

All types of submissions / papers should follow a standard format as described below.

Editorials:

Usually provide commentary and analysis concerning an article in the issue of the Journal in which they appear. They may include figures and tables. They are always solicited. The editorials would be limited to 1000 words with up to 10 references.

Original Articles:

Reports of original clinical and basic research of interest to the medical community are the primary material to be published as original articles. Randomly controlled trials intervention studies, studies of screening and diagnostic tests, outcome studies, cost-effectiveness analysis, case-control series, and surveys with a reasonably high response rate. The text would be limited to 3000-3500 words, with an abstract of 250 words, maximum of 5 tables and figures (total) and up to 40 references.

Reviews and Clinical Debates:

An article review is both a summary and an evaluation of another writer's article. They would cover a contemporary topic and would generally be wide-ranging overviews of a field of research. The reviews and clinical debates will be subject to the standard review process. The minimum word length would be 3000 and maximum would be 3500 words with 50 references.

Case Reports/Study:

The Journal encourages the submission of case reports that highlight practical diagnostic and/or management considerations. The format of these papers should follow that described in the “Manuscript Components” section above. Identifying information within written descriptions, photographs, or pedigrees should not be given.

Case Series:

Case-series is a descriptive study design and as the name suggests, it is just a series of cases of any particular disease or disease discrepancy that one might observe in one's clinical practice etc.

Letters to the Editor:

The Journal accepts Letters to the Editor that raises some issues related to recently published articles (last 2 issues) in the Journal. The letters should not exceed (1000 words) of text and 5 references. While not all “Letters to the Editor” will be published, those that are judged worthwhile will be forwarded to the authors of the articles in question or to selected experts in order to provide the opportunity for a response. Whenever possible, they will be published with the reply of the author of the published article.

Manuscript Preparation

The manuscript must have separate documents for:

• Cover letter,
• Research Article/Case Review/Original Research/Review Article file (without author/ institution) along with Figure/Table/Graph/Flowchart (with descriptive legends) doc.

Manuscript Components

Microsoft Word 97-2013 or higher document file must be used to submit a manuscript. The text must be double spaced with 1” margins and justified to the left-hand margin. Avoid using “styles” or document templates. The “Normal” Word format is recommended. (Times New Roman-12 point text is expected) Please number all pages.

TITLE

The title of the manuscript should appear at the top of the first page. The title must clearly state what the article is about.

Cover Letter

A cover letter is a letter addressed to the Editor-in-Chief of the journal stating why the journal should consider your article for publication.

Title Page

It includes Article title, 5 keywords, abstract and article text.

Corresponding Address: Submitted on web during submission. No author details must be mentioned on the article file.

Short title: A short title that is running head of no more than 45 characters, including spaces to be provided.

Author Names

Do not include author names in the manuscript in order to preserve anonymity during the review process. Authors' names need to be included during submission metadata while submitting the file on the journal's web site.

Keywords

A list of minimum 3 to upto 5 keywords contained in the article must be listed below the abstract. They should contain the type of research such as systematic review, randomized clinical trial, cohort study, case-control study, laboratory research, or "other". (These will be used to search for your article on PubMed and other Internet resources.)

Abstract

All articles must include a structured abstract of approximately 200 to 250 words and only include material appearing in the main body of the manuscript. Authors are required to indicate the relevance in a statement of clinical significance within the abstract of the manuscript as well as at the end of the main body of the text.

Structured abstracts vary according to the type of article. All abstracts must be organized into a structured format appropriate to the type of article using the headings listed in the following table:

 

BODY OF THE MANUSCRIPT

The body of the manuscript must be organized into a format appropriate for the type of article using bold headings as listed in the following table:

Primary Research      Literature Reviews          Case Reports                   Clinical Techniques

Introduction                    Background                      Background                     Background

Materials & Methods      Review Results                Case Description             Technique

Results                              Discussion                        Discussion                         Discussion

Conclusion                       Clinical Significance       Clinical Significance          Clinical Significance

Clinical Significance        Acknowledgment            Acknowledgment            Acknowledgment

References                       References                       References                        References

 

Abbreviations: Spell out all abbreviations (other than those for units of measure) the first time they are used; idiosyncratic abbreviations should never be used.

Drugs Name: Generic rather than trade names of drugs should be used.

 

References:

References are numbered in the text, either in line with the text within brackets (1) or using superscript¹ , in the increasing order in which they appear. A reference which is cited more than once is given the same number. The references are then listed at the end of the text in numerical order by their order of appearance in text. Do not arrange the list alphabetically. References in tables and figures are numbered as though the tables and figures were part of the text. References should be restricted to closely pertinent material. Accuracy of the citation is the author’s responsibility. References should conform exactly to the original spelling, accents, punctuation, etc. Authors should ensure that all references listed have been cited in text. Personal communications, unpublished manuscripts, manuscripts submitted but not yet accepted, and similar unpublished items should not appear in the reference list. Such citations may be noted in text. It is the author’s responsibility to obtain permission to refer to another individual’s unpublished observations. Manuscripts that are in press may be cited as such in the reference list; the name of the journal or publisher and location must be included. References to the editions of DSM should not be included in the reference list. DOI of the references should be included wherever available.

Type references in the Vancouver style shown below. Abbreviations of journal names should conform to the style used in “NLM Catalog: Journals referenced in the NCBI Databases” (http://www.ncbi.nlm.nih.gov/nlmcatalog/journals); journals not indexed there should not be abbreviated.

1. Zinbarg RE, Barlow DH, Liebowitz M, et al: The DSM-IV field trial for mixed anxiety-depression. Am J Psychiatry 1994; 151:1153-1162
   
   
2. Beahrs JO: The cultural impact of psychiatry: the question of regressive effects, in American Psychiatry After World War II: 1944-1994. Edited by Menninger RW, Nemiah JC. Washington, DC, American Psychiatric Press, 2000, pp 321-342
   
   
3. Burrows GD, Norman TR, Judd FK, et al: Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders. J Psychiatr Res 1990; 24(suppl 2):65-72
   
   

TABLES
The Journal does not publish tables that have been submitted elsewhere or previously published. Tables that duplicate material contained elsewhere in the manuscript (in text, figures, or other tables) will not be used. Authors should delete tables containing data that could be given succinctly in text. A copy of each table must be submitted with the manuscript in an editable format and must be accessible for copyediting. Tables cannot be embedded within the document or provided as figure art. In terms of data presentation, values expressed in the same unit of measurement should read down, not across; when percentages are presented, the appropriate numbers must also be given. In preparing the tables, each cell should contain only one item of data. In rows, subcategories should be in separate cells; in columns, Ns and %s or Means and SDs should be in separate cells. For optimum readability and presentation, tables should not exceed 120 characters in width.

FIGURES
Figures express trends or relationships between data. Consult recent issues of the Journal and the following guidelines for format. Figures that contain numerical data that could be expressed more succinctly or clearly in tabular form should be converted to tables. Submission of previously published figures is discouraged. Multiple figures for the same article should be prepared as a set, consistent in color and size across all figures.

 Submission

1. A copy of each figure must accompany the manuscript.
2. Figure titles and footnotes should be provided within the text of the manuscript.
3. If figures have been previously adapted from an earlier publication, the author must secure written permission from the holder of copyright for use in the Journal. The author should submit a copy of the permission release and credit lines if the manuscript is accepted for publication.
    

Format

1. Specific file formats are required for different types of figure images. For photos or scans, high resolution (300 dpi) raster images in .jpg, .png, or .tiff formats are preferred. For charts and graphs, scalable and editable vector images in .eps, .pdf, or .svg formats should be provided. We can also accept native files for charts and graphs created in Word, PowerPoint, or Adobe Illustrator.
2. Definitions of symbols appearing in the figure should be presented in a key within the figure, rather than in the title or footnotes.
3. Except for the key, avoid using internal type (e.g., placing statistical values within a graph).
4. Two-dimensional graphs should not be represented in three dimensions.
   
   

Content

1. Each complete figure (including titles and footnotes) should be understandable without reference to the text.
2. Figures should represent data visually rather than numerically.
3. If error bars are included, standard deviations, rather than standard errors of the mean, should be used.
4. Only the most widely recognized abbreviations may be used.
5. In a graph comparing different groups of subjects, the number of subjects in each group should appear with the name of the group—in the key, in the headings below the horizontal axis, or in the title.
6. Ordinary footnotes should be cited with lower-case superscript letters. Footnote citations may be given in both the title and the body of the figure; within the body of the figure, they should proceed from left to right.
7. For statistical comparisons noted in figures, provide complete statistical data in footnotes. If numerous analyses are presented, simple p values may be given in the footnotes, in which case the footnotes should be indicated by single asterisk, double asterisk, etc.

SUPPLEMENTAL DATA
The Journal doesn’t allow authors to submit supplemental data to be posted online in support of their printed articles. To be accepted for posting, supplemental material must be essential to the scientific integrity and excellence of the manuscript. The material is subject to the same editorial standards as the printed Journal and will be submitted for peer review. Supplemental material will not be formatted or edited by in-house editorial staff to the extent as performed for material appearing in the print version. The Editor may select material submitted for publication in the print version to be posted online only. The Journal will accept the following categories of supplemental data:

• Detailed tables (up to 3) that contain data of use to other investigators. Data should be summarized in the text of the print version
• The CONSORT table and figure for clinical trials are also appropriate for online publication only.
• Questionnaires, tests, checklists, etc., should be submitted as supplemental data.

Supplemental data should be uploaded in a separate file from the for-print manuscript. Please remember that the larger the file size the longer it will take users to download. For this reason, please limit your files to 10 MB. The Journal can accept the following formats:

• Plain text (.txt)
• HTML page (.html)
• JPEG image (.jpg)
• GIF image (.gif)
• Adobe PDF (.pdf)
• Excel spreadsheet (.xls)
• ZIP compressed file (.zip)
• Word document (.doc)
• Tiff image (.tif)
• PowerPoint presentation (.ppt)
• Encapsulated Postscript document (.eps)
• Mp3 file (.mp3)
• QuickTime video
  
  

If your document type is not listed here, please contact the editorial office at 9vom365@gmail.com. Please name your files and cite within the printed text as ST1 for tables, SF1 for figures, SR1 for references, and SA1 for appendices.

Processing of Accepted Manuscripts

Manuscripts are accepted with the understanding that the Editor and the editorial staff have the right to make revisions aimed at greater conciseness, clarity, and conformity with Journal style. Preliminary page proofs will be sent to the corresponding author. Authors who will be away from their offices for a long period or who change address after notification of acceptance should inform the Journal staff.

Reviewers

Becoming a Reviewer
Individuals interested in reviewing should visit JSPlaS manuscript review system and create an account by registering themselves.

Abstracts of articles within a reviewer’s given area of expertise are sent via e-mail to the reviewer. Usually, within 3 days, the reviewer is asked to indicate willingness to review and availability to perform the review within a 2-week time frame.

Competing Interests
Most competing interests, financial or otherwise, do not disqualify one from participating in the peer-review process, but the Journal requests that you indicate any conflict that you may have in reviewing any particular manuscript. You can also notify the Journal if you feel that you cannot review a manuscript because of a competing interest. This will not affect your reviewer status in any way.

Confidentiality
Manuscripts must be reviewed with due respect for authors’ confidentiality. In submitting their manuscripts for review, authors entrust the Journal with the results of their scientific work and creative effort, on which their reputation and career may depend. Authors’ rights may be violated by disclosure of the confidential details of the review of their manuscript. Reviewers should never copy, share, or discuss a manuscript under review or the data within with anyone without expressed written permission of the Journal’s Editor and the authors.

The authors are required to share the author/affiliation details in only cover letter as separate file or during submission on the website.

For any more details, feel free to write to us at 9vom365@gmail.com.